PitchSend

Investor Presentaiton

ersonal use only 5 Key achievements in 2020 CE mark approval received enabling the sale of Imricor's products in the European Union Successful commercial launch at Heart Centre Dresden also providing training to future sites 9 sites contracted¹ with a growing pipeline of new sites Sales agreement with Philips enabling Philips to sell Imricor's capital equipment as part of iCMR lab installation package ווי - Strategic agreements signed that further promote future iCMR lab adoption Solid progress on growth strategies remaining on track with initiatives to expand indications and geographies 1. As at 30 December 2020 Imricor FY20 Investor Presentation, February 2021

View entire presentation